Porphyric neuropathy

@article{Albers2004PorphyricN,
  title={Porphyric neuropathy},
  author={James W. Albers and John K. Fink},
  journal={Muscle \& Nerve},
  year={2004},
  volume={30}
}
The hepatic porphyrias are a group of rare metabolic disorders characterized by enzymatic defects in the biosynthesis of heme, a metalloporphyrin that is the principal product of porphyrin metabolism. The hepatic porphyrias are genetically transmitted as autosomal‐dominant disorders with variable expression that produce a particularly severe form of neuropathy. Most medical students readily recognize acute attacks of porphyria when the classic triad of abdominal pain, psychosis, and neuropathy… 
Acute porphyrias – A neurological perspective
TLDR
The diagnostic difficulties are highlighted by presenting three cases from the neurological intensive care unit and a comprehensive overview about the diagnostic findings in imaging, electrophysiology, and neuropathology is given.
Porphyria-induced Recurrent Quadriplegia Misdiagnosed as Guillain–Barré Syndrome
TLDR
Even though porphyric neuropathy can be a challenging diagnosis, accurate diagnosis is crucial to avoid permanent damage to peripheral nerves and prevent life-threatening attacks.
Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations
TLDR
The current knowledge regarding the main pathophysiological mechanisms involved with the acute and chronic presentation of acute hepatic porphyria are presented to highlight the relevance of such content for clinical practice and in decision making about therapeutic options.
Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management
TLDR
The diagnosis of porphyric neuropathy remains challenging as varying neuropathic patterns are encountered depending on disease stage, including a non-length-dependent distribution pattern, and its long-term effects on motor recovery, chronic pain, and dysautonomic manifestations are yet to be determined.
Brainstem dysfunction in variegate porphyria
TLDR
It is hypothesized that brainstem dysfunction in VP patients with a history of porphyric crises may be due to neurotoxic effects of porphyrin precursors as well as subclinical osmolarity changes due to hyponatremia.
Normal reference ranges for urinary δ‐aminolevulinic acid and porphobilinogen levels
TLDR
Urinary ALA and PBG levels were quantified in 150 healthy subjects using a validated liquid chromatography tandem mass spectrometry (LC‐MS/MS) method that is highly sensitive, specific, accurate, and reproducible to assess the effectiveness of therapeutic interventions in lowering ALAand PBG.
Acute intermittent porphyria (AIP) in a patient with celiac disease
TLDR
This case shows the importance of early and systematic symptomatic treatment in patients with severe neurologic manifestation of AIP, and the first case of acute intermittent porphyria triggered by malnutrition in the context of celiac disease.
Paediatric porphyria and human hemin: a treatment challenge in a lower middle income country
TLDR
This is the first reported case of treatment of acute intermittent porphyria with human hemin in Pakistan, and increased lactic acid and blood urea nitrogen were the two side effects observed after the treatment.
Acute intermittent porphyria after gastroplasty.
TLDR
A 28-year-old female who underwent gastroplasty for obesity in an uneventful procedure was followed within five days by persistent abdominal pain associated with weakness that progressed to generalized flaccid quadriparesis, which indicated the diagnosis of acute intermittent porphyria.
...
1
2
3
4
...

References

SHOWING 1-10 OF 110 REFERENCES
The Porphyrias: Characteristics and Laboratory Tests [corrected title]
TLDR
Tests for porphyria are becoming included increasingly in examinations of persons who have experienced problematic chemical exposures because both inheritable and noninheritable forms of porphyrias can be induced by toxic chemicals.
THE NEUROLOGICAL MANIFESTATIONS OF PORPHYRIA: A REVIEW
TLDR
The hereditary hepatic porphyrias, PV, AIP and HC, are characterized clinically by episodes of acute neurological involvement, and work from a number of research groups has shown the porphyrin precursors to have potent pharmacological effects on the nervous system, and these are possibly related to the GABA receptor and binding site-porphyrin precursor interactions.
Acute porphyrias in the Argentinean population: a review.
TLDR
To screen for mutations in symptomatic patients, a geneticresearch strategy is proposed and all the mutations found in 46 AIP and 9 VP unrelated Argentinean patients are reviewed.
Management of acute and cutaneous porphyrias.
TLDR
The porphyrias comprise a group of disorders of the haem biosynthesis pathway that can present with acute neurovisceral symptoms, skin lesions or both and should be instituted as soon as possible following confirmation of increased excretion of porphobilinogen in the urine.
Human hereditary hepatic porphyrias.
  • Y. Nordmann, H. Puy
  • Medicine
    Clinica chimica acta; international journal of clinical chemistry
  • 2002
Electromyogram and nerve conduction in patients with acute intermittent porphyria
TLDR
Electromyographic and neurographic investigations were performed on 20 persons with AIP and motor nerve conduction velocity was mostly decreased in combination with denervation signs and in a range that indicated a primarily axonal nerve lesion and consequent myelin damage rather than primary demyelinization.
Erythropoietic and hepatic porphyrias
TLDR
The recognition of the overt disorder with extrahepatic manifestations depends on the demonstration of biochemical abnormalities due to these primary defects and compensatory hepatic overexpression of hepatic δ-aminolaevulinic acid synthase in the acute porphyrias.
Porphyrinurias and Occupational Disease a
  • M. Doss
  • Medicine
    Annals of the New York Academy of Sciences
  • 1987
TLDR
Secondary porphyrinuria with transition to chronic hepatic porphyria is a metabolic response following various toxic and pathologic conditions; it serves as a sensitive index for chemical exposure and occupational disease.
Treatment with haematin in acute hepatic porphyria.
TLDR
The experience with intravenous haematin in the treatment of 13 attacks of acute porphyria in eight patients found that biochemical improvement was a consistent finding and clinical response has been less consistent.
Pathogenesis of acute porphyria.
TLDR
The pathogenesis of the clinical manifestations of acute porphyria has been considered and the neurological manifestations may be explained by a deficiency of haem in neural tissues; the porphyrin precursor 5-aminolaevulinic acid (ALA) may have in addition specific pharmacological activity.
...
1
2
3
4
5
...